Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03809988
Title PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications

Her2-receptor negative breast cancer

Therapies

Fulvestrant

Fulvestrant + Palbociclib

Letrozole

Letrozole + Palbociclib

Age Groups: senior | adult
Covered Countries


No variant requirements are available.